Datum: 2.4.2008
The unique study of UCS biologists proposes a new paradigm in cancer treatment: Instead of selectively attacking cancer cells, protect all other cells against chemotherapy.
Making chemotherapy more selective has been a top cancer research goal for decades. Now, the animal studies and in vitro human cell studies show that a two days fast protects healthy cells against chemotherapy, while tumor cells remain sensitive to the drugs. Mice given a high dose of chemotherapy after fasting continued to thrive. The same dose killed half the normally fed mice and caused lasting weight and energy loss in the survivors.
"In theory, it opens up new treatment approaches that will allow higher doses of chemotherapy. It's a direction that's worth pursuing in clinical trials in humans," say the researchers at University of Southern California. Fasting before chemotherapy has still unknown risks and benefits for humans. The effectiveness and safety of the method will be established by future clinical trials.
Source: http://www.usc.edu
Mendel lectures: How DNA recombination maintains genome integrity
Mendel museum, Brno, April 15, 2010
Mendel lectures: Germ cell specification in mice
Mendel museum, Brno, April 29, 2010
Mendel lectures: Cell membrane organisation and lipid rafts
Mendel musem, Brno, May 13, 2010
The Second International Conference on Biological and Environmental Sciences (2ICBES)
Mansoura and Luxor, Egypt, March 15-20, 2010
XGen Congress
San Diego, CA, United States, March 15-19, 2010
Drug Discovery Technology World Asia 2010
Singapore, March 16-19, 2010
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
© 2006 South Moravian Innovation Centre
Interesting biotechnology content:
Science - Daily Czech science news
Biotechnology Journals - Plant, environmetal, animal biotechnology journals
Breakthrough Flu Drug Might Already Exist
Cocaine Vaccine Shows Promise for Treating Addiction